Mixed Signals Prompt Capital Shifts From AI Bets to Defensive YieldsGlobal Report·Aug 20 at 10:16 AMINM-2.22%VTS+0.86%
The Capital Restructuring Wave: Major Shifts Across Diverse SectorsGlobal Report·Aug 7 at 09:18 AMPRU-0.39%GCT-2.39%
Strategic Shifts Heat Up: Inside Intapp's AI Rollout and Photronics' Lingering CrisisGlobal Report·Aug 5 at 09:13 AMINTA-2.65%POLA+0.72%
Under the radar: How US niche equities navigate AI, defense, and global M&AGlobal Report·Jul 30 at 09:13 AMASPC+1.47%LHAI-3.34%
Marginal Assets in Global Rotation: 10 US Stocks Reflecting Cross-Border DivergenceGlobal Report·Jul 29 at 09:18 AMSGML-3.01%BOT-2.80%
The 2026 Earnings Paradox: Record Revenues Meet Hidden Credit CracksGlobal Report·Jul 26 at 09:18 AMEADSY-0.95%NSC-2.87%
The Biotech Survival Charade: Stop Buying the "AI Pivot" HypeGlobal Report·Jul 26 at 09:14 AMINM-2.22%ONCY+0.21%
The Great Unbundling of 2026: From AI Platforms to Physical ConstraintsGlobal Report·Jul 25 at 09:14 AMMELI+1.41%HUBS-3.92%
The 2026 Biotech Divide: When Generative Biology Meets the FDA WallGlobal Report·Jul 24 at 09:13 AMINM-2.22%TXG-3.96%
Pre-market hot trades in US stocks: AsiaStrategy pre-market down 9.91%; InMed Pharmaceuticals pre-market down 9.04%Price Alert·Jul 24 at 09:12 AMSORA+8.90%INM-2.22%
InMed Pharmaceuticals rises 8% in after-hours tradingUS Stock Market Update·Jul 22 at 09:21 PMINM-2.22%
InMed Pharmaceuticals surges 12% during regular trading on volumeUS Stock Market Update·Jul 22 at 06:52 PMINM-2.22%
Mentari Therapeutics merger with InMed set to close ahead of USD 200 million private placementPUBT·Jul 22 at 11:05 AMINM-2.22%
InMed Pharmaceuticals surges 14% during regular tradingUS Stock Market Update·Jul 22 at 04:11 PMINM-2.22%
InMed Pharmaceuticals surges 33% during regular trading on heavy volumeUS Stock Market Update·Jul 22 at 01:40 PMINM-2.22%